Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 19, 19:50
535.60
-4.75 (-0.88%)
VOLUME 62,070
LIVE
NSE
Oct 19, 19:49
535.75
-4.45 (-0.82%)
VOLUME 434,929
Announcements on Sun Pharma

17th-Oct-2017 17:22Source: BSE

Sun Pharmaceutical Industries- Shareholding for the Period Ended September 30, 2017

Sun Pharmaceutical Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly

12th-Oct-2017 16:05Source: BSE

Sun Pharma- Updates on Acquisition

This is to inform you that one of the wholly owned subsidiaries of the Company has agreed to increase its shareholding in Ranbaxy Malaysia Sdn Bhd, Malaysia, by way of purchase of 666,985 shares of fa...

11th-Oct-2017 17:21Source: BSE

Sun Pharma- Updates

This is with reference to our letters dated April 21, 2017 to the stock exchanges providing our clarification on the US FDA inspection at the Company''s Dadra facility wherein interalia we had indicat...

10th-Oct-2017 15:08Source: BSE

Sun Pharma- Investor Grievance Report As Per Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

As required by Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below Statement of Investor Complaints for the quarter ended 30th September...

7th-Oct-2017 15:47Source: BSE

Sun Pharma- Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that all activities in relation to both physical and elect...

4th-Oct-2017 19:49Source: BSE

Sun Pharma- Credit Rating

Sun Pharmaceutical Industries Limited has informed the Exchange regarding Credit Rating of Commercial Paper of the Company by CRISIL.

3rd-Oct-2017 16:09Source: BSE

Sun Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia

28th-Sep-2017 11:18Source: BSE

Sun Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Valia

28th-Sep-2017 10:35Source: BSE

Sun Pharma- Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly

27th-Sep-2017 20:43Source: BSE

Sun Pharma- Scrutinizer's Report

Voting Results of Twenty Fifth Annual General Meeting of the Company held on September 26, 2017 along with Scrutinizer's Report.

1 2 3 4 5 Next >>
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.